Characterization and fractionation of SARS-CoV-2 specific IgG from COVID-19 convalescent and post-vaccine group

Purpose: This study aimed to explore the method for characterization and fractionation of SARS-CoV-2 IgG specific from convalescent COVID-19 patients, post-inactive, and post-mRNA vaccines Patients and methods: The procedures include blood sample collection, SARS-CoV-2 specific IgG content screening...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bali medical journal Jg. 14; H. 1; S. 254 - 258
Hauptverfasser: Purwati, Nora Ertanti, Deya Karsari, Aristika Dinaryanti, Eryk Hendrianto, Igo Syaiful Ihsan, Asa Ardiana, Nanis Nurdiyati, Adita Ayu Permanasari, Bagus Satrio Nurwito, Andang Miatmoko
Format: Journal Article
Sprache:Englisch
Veröffentlicht: 01.01.2025
ISSN:2089-1180, 2302-2914
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Purpose: This study aimed to explore the method for characterization and fractionation of SARS-CoV-2 IgG specific from convalescent COVID-19 patients, post-inactive, and post-mRNA vaccines Patients and methods: The procedures include blood sample collection, SARS-CoV-2 specific IgG content screening, IgG fractionation, and validate specific IgG. Statistical analysis was carried out to evaluate the significance value of SARS-CoV-2 IgG presence in each sample group. Results: The results showed that the post-mRNA vaccine samples had the highest levels of SARS-CoV-2 IgG antibodies. Furthermore, the validation was confirmed to be specific to SARS-CoV-2 IgG, as indicated by the heavy and light chains marked at ~50kDa and 25kDa, respectively. Conclusion: A significant difference between the SARS-CoV-2 IgG content between the three sample groups is indicated by a P value of 0.0043.
AbstractList Purpose: This study aimed to explore the method for characterization and fractionation of SARS-CoV-2 IgG specific from convalescent COVID-19 patients, post-inactive, and post-mRNA vaccines Patients and methods: The procedures include blood sample collection, SARS-CoV-2 specific IgG content screening, IgG fractionation, and validate specific IgG. Statistical analysis was carried out to evaluate the significance value of SARS-CoV-2 IgG presence in each sample group. Results: The results showed that the post-mRNA vaccine samples had the highest levels of SARS-CoV-2 IgG antibodies. Furthermore, the validation was confirmed to be specific to SARS-CoV-2 IgG, as indicated by the heavy and light chains marked at ~50kDa and 25kDa, respectively. Conclusion: A significant difference between the SARS-CoV-2 IgG content between the three sample groups is indicated by a P value of 0.0043.
Author Deya Karsari
Nora Ertanti
Aristika Dinaryanti
Eryk Hendrianto
Igo Syaiful Ihsan
Nanis Nurdiyati
Adita Ayu Permanasari
Bagus Satrio Nurwito
Andang Miatmoko
Purwati
Asa Ardiana
Author_xml – sequence: 1
  surname: Purwati
  fullname: Purwati
– sequence: 2
  surname: Nora Ertanti
  fullname: Nora Ertanti
– sequence: 3
  surname: Deya Karsari
  fullname: Deya Karsari
– sequence: 4
  surname: Aristika Dinaryanti
  fullname: Aristika Dinaryanti
– sequence: 5
  surname: Eryk Hendrianto
  fullname: Eryk Hendrianto
– sequence: 6
  surname: Igo Syaiful Ihsan
  fullname: Igo Syaiful Ihsan
– sequence: 7
  surname: Asa Ardiana
  fullname: Asa Ardiana
– sequence: 8
  surname: Nanis Nurdiyati
  fullname: Nanis Nurdiyati
– sequence: 9
  surname: Adita Ayu Permanasari
  fullname: Adita Ayu Permanasari
– sequence: 10
  surname: Bagus Satrio Nurwito
  fullname: Bagus Satrio Nurwito
– sequence: 11
  surname: Andang Miatmoko
  fullname: Andang Miatmoko
BookMark eNotkE9rwjAYxsNwMOc875ovEM2bpGl7lG5zgiDMzWuJ6RsX0aY0nbB9eqvu9Pzh4Tn8HsmgDjUS8gx8AkmixXR73E9OoDxMEi6zOzIUkgsmclCD3vMsZwAZfyDjGPecc5AaZM6HJBTfpjW2w9b_mc6Hmpq6ou5S9eHWBEfXs481K8KGCRobtN55Sxe7eT8MR1qsNosXBjm1oT6ZA0aLdXf9aULs2MlY62ukuzb8NE_k3plDxPG_jsjX2-tn8c6Wq_mimC2ZBa07prZOOSOslSilTSqttcIURZ6mKbg8R5OlUOlKqCzLKo4STWpQi61RQvRrOSLT269tQ4wturJp_dG0vyXw8oqs7JGVV2TlBZk8A940Ye4
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.15562/bmj.v14i1.5038
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2302-2914
EndPage 258
ExternalDocumentID 10_15562_bmj_v14i1_5038
GroupedDBID 5VS
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
CITATION
KQ8
RNS
ID FETCH-LOGICAL-c166t-4bf4fa2cc3e33c5d6664e7e297771f99ea871d6d24888d0e3ea7ae62ba422d663
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001528702300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2089-1180
IngestDate Thu Oct 09 00:21:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c166t-4bf4fa2cc3e33c5d6664e7e297771f99ea871d6d24888d0e3ea7ae62ba422d663
OpenAccessLink https://doi.org/10.15562/bmj.v14i1.5038
PageCount 5
ParticipantIDs crossref_primary_10_15562_bmj_v14i1_5038
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationTitle Bali medical journal
PublicationYear 2025
SSID ssj0001361390
ssib044731098
Score 2.2788305
Snippet Purpose: This study aimed to explore the method for characterization and fractionation of SARS-CoV-2 IgG specific from convalescent COVID-19 patients,...
SourceID crossref
SourceType Index Database
StartPage 254
Title Characterization and fractionation of SARS-CoV-2 specific IgG from COVID-19 convalescent and post-vaccine group
Volume 14
WOSCitedRecordID wos001528702300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2302-2914
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssib044731098
  issn: 2089-1180
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaWghAXxFO85QMHpJVL4jhxfKy2BXpoQbRUvUVObFctkFS726Vc-C_8U2bixElbIZUDl2hlWbOP-XZenvlMyOuktMaYKGKllBETpdSsBL_CLMQSMtYuy4VpL5uQu7v54aH6NJn87mdhVt9kXefn5-r0v6oa1kDZODr7D-oOQmEBXoPS4Qlqh-e1FD8LFMx-wrI9HnBzP8AQAsS9jc97bNYcMD7FYUtsGJpuH7334yazjwfbmyxWbU-67hifPKVAs1iyla7wOH56FOpW_akwBPX-tH7gpAi292z-A949FJ8BemCE8Q7jsLZpf2qcTltA_j4AEY3QVw22GQeHw_auUMHTUaGitWc8yhVDxjnvevxagtPhys-RBoMsrgCvs66eb7pz1Nxzvl_xASmEdKCk8vvJ-ioWx_E6Mt4M7q4_4r_kBUNvImZFKKIAAUUroEABN8hNLlOFXYM7v7Z6kyWERGrVfCjrJRAftZW98HU7QimU-fbihxrFQqOgZv8eudtlI3TDo-g-mdj6Abm90_VbPCTNZTBRAAG9ACbaODqAifZgogAmimCiPZjoGEytnDGYaAumR-TLu6392QfWXdHBqjjLlvDndsJpXlWJTZIqNZAMCysth6xCxk4pqyEhN5nh4CdyE9nEaqltxkstOIfdyWOyVje1fUJoqWIdpaXhLoKYWBnlQJ4yuXNa2NSpp-RN_2MVp56JpfiLrp5df-tzcmfA6guytpyf2ZfkVrVaHi_mr1pd_wFnQ4Iy
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+and+fractionation+of+SARS-CoV-2+specific+IgG+from+COVID-19+convalescent+and+post-vaccine+group&rft.jtitle=Bali+medical+journal&rft.au=Purwati&rft.au=Nora+Ertanti&rft.au=Deya+Karsari&rft.au=Aristika+Dinaryanti&rft.date=2025-01-01&rft.issn=2089-1180&rft.eissn=2302-2914&rft.volume=14&rft.issue=1&rft.spage=254&rft.epage=258&rft_id=info:doi/10.15562%2Fbmj.v14i1.5038&rft.externalDBID=n%2Fa&rft.externalDocID=10_15562_bmj_v14i1_5038
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2089-1180&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2089-1180&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2089-1180&client=summon